[Normalization of ventricular compliance and hypertrophy in arterial hypertension. Double-blind study with 2 combinations of a beta blocker and diuretic].
Mohallen
K L
KL
do Patrocínio
L L
LL
Célnik
D
D
Kruczan
D D
DD
Pinheiro
L
L
Weitzel
L H
LH
Bosco
J
J
Sekeff
J A
JA
Azevedo
A de C
Ade C
D000328:Adult; D001262:Atenolol / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D006332:Cardiomegaly / Q000188:drug therapy*; D002752:Chlorthalidone / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D004548:Elasticity; D005260:Female; D006352:Heart Ventricles / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009200:Myocardial Contraction / Q000187:drug effects*
D001262:Atenolol; D002752:Chlorthalidone
A normalização da complacência e da hipertrofia ventricular na hipertensão arterial. Estudo duplo-cego com duas associações de betabloqueador e diurético.